Qiaoshuai Lan

机构：Chinese University of Hong Kong, Hong Kong Science and Technology Parks Corporation, University of Hong Kong · ORCID：0000-0001-5524-3542

发表论文 32 篇 · 总被引 3224 次 · h-index 17

代表论文

• The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin (2020 · Signal Transduction and Targeted Therapy · 被引 363)
• V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity (2021 · Journal of Virology · 被引 114)
• Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation (2021 · Signal Transduction and Targeted Therapy · 被引 69)
• Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant (2022 · Cell Research · 被引 40)
• A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases (2021 · Acta Pharmaceutica Sinica B · 被引 37)
• Pan‐coronavirus fusion inhibitors to combat COVID‐19 and other emerging coronavirus infectious diseases (2022 · Journal of Medical Virology · 被引 30)